Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01117168 : Enrollment on the Childhood Cancer Research Network (CCRN) of the Children s Oncology Group
AgesMin: N/A Max: 18 Years

- Pre-CCRN Entry

- All new patients seen in COG member institutions with any of the following diagnoses
are eligible:

- All cancer cases with an ICD-O histologic behavior code of two 2 (carcinoma in
situ)or three 3 (malignant).

- All lesions of the central nervous system regardless of behavior, i.e., benign,
borderline or malignant.

- The benign/borderline conditions which will be reportable by agreement shall
include: Mesoblastic nephroma, all teratomas, regardless of locations, Theca

- granulosa cell tumor, lymphoproliferative disease, ganglioneuroma,

myeloproliferative disease, Langerhan s Cell histiocytosis
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557